Research ArticleConference Proceeding
Session 3.1: Protein A, Hydroxyapatite, and Mixed-Mode Chromatography
Dayue Chen
PDA Journal of Pharmaceutical Science and Technology September 2016, 70 (5) 443-450; DOI: https://doi.org/10.5731/pdajpst.2016.006932
Dayue Chen
Bioprocess Research & Development, Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285; (317) 433-7629;

References
- 1.↵
- Hubbard B.,
- Roush D.
- 2.↵
- Hubbard B.
- 3.↵
- Connell-Crowley L.,
- Larimore E. A.,
- Gillespie R.
In This Issue
PDA Journal of Pharmaceutical Science and Technology
Vol. 70, Issue 5
September/October 2016
Session 3.1: Protein A, Hydroxyapatite, and Mixed-Mode Chromatography
Dayue Chen
PDA Journal of Pharmaceutical Science and Technology Sep 2016, 70 (5) 443-450; DOI: 10.5731/pdajpst.2016.006932
Jump to section
- Article
- Introduction
- 3.1.1. Viral Clearance of the Capto Adhere Chromatography Step In Monoclonal Antibody (mAb) Purification Processes (Junfen Ma; Pivotal Purification Process Development Amgen Inc., Cambridge, MA)
- 3.1.2. Clearance of XMuLV and Minute Virus of Mice (MVM) by Ceramic Hydroxyapatite (HAP), Mixed-Mode and Anion Exchange (AEX) Chromatography for Pharmaceutical Antibodies with Low pI (Seiryu Ujiie; Chugai Pharmaceutical Co., Ltd, Tokyo, Japan)
- 3.1.3. Virus Clearance Robustness for Multimodal AEX Chromatography (Sherrie Curtis; Genentech Inc., South San Francisco, CA)
- 3.1.4. Evaluation of the Viral Clearance Capacity and Robustness of the Manufacturing Process for the Recombinant Factor VIII (rFVII) Protein, Turoctocog Alfa (Søren Kamstrup; NovoNordisk A/S, Gentofte, Denmark)
- 3.1.5. Evaluation of Agarose-Based Protein A Chromatography as a Reliable Virus Removal Step: Modeling and Outlier Analysis (John Ruppino and John Mattila; Regeneron, Tarrytown, NY)
- Summary
- Footnotes
- References
- Figures & Data
- References
- Info & Metrics
Related Articles
- No related articles found.